Telangana has embarked on enormous infrastructure development projects in order to compete worldwide and attract investments, according to state Industries and Commerce Minister K.T. Rama Rao. He mentioned the development of the Kakatiya Mega...
On Monday, premarket trading saw a sharp increase in the shares of several cancer drug companies after the companies presented encouraging clinical trial results for their treatments at a Chicago industry conference...
Danish drug developer Novo Nordisk said on Monday it had started talks to buy a controlling stake in French medical device designer Biocorp.The Danish company said it had entered into exclusive negotiations with Bio Jag, Biocorp's main shareholder,..
Eyestem Research has announced that it has submitted an Investigational New Drug (IND) application to the Central Drugs Standards Control Organisation, India (CDSCO) to begin the first in-human trials of Eyecyte-RPE for subjects with medium- to...
Dr Reddy's Laboratories Ltd announced that its DRL_TC tocilizumab biosimilar candidate met primary and secondary endpoints in a Phase I study. This Phase I study compared the pharmacokinetic equivalence, safety, and immunogenicity of Dr. Reddy's ...
Coherus BioSciences Inc said last week it plans to launch a biosimilar of AbbVie Inc's Humira in July at a list price of $995 per carton, representing a discount of about 85 per cent from the bzlockbuster arthritis drug...
Hyderabad, known as India's pharma hub, is home to 214 USFDA-approved facilities, and as the pharma market grows due to complex molecules, companies will be forced to invest in and build future state-of-the-art labs, according to a Dr Reddy's...
Anil Khubchandani has been appointed as managing director and CEO of Sekhmet Pharmaventures Pvt Ltd, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies, by a private...
AstraZeneca, a British-Swedish pharmaceutical company, announced this week that its anti-liver cancer drug tremelimumab combination has been approved by India's drug regulator...
A new study has termed mRNA technology a ‘game-changer’ for Asia-Pacific (APAC) vaccine manufacturers. The study, sponsored by science and technology company Merck, surveyed nearly 40 manufacturers. Out of which, eighty-seven per cent of those...
, CDSCO.jpg)
